Whitney C Driver
Obstetrics/Gynecology · Oklahoma City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 18 years
- University of Oklahoma College of Medicine, 2008
Offices
1 location · Oklahoma City Gynecology and Obstetrics, LLC · 22 clinicians in this group
Hospitals listed: Integris Baptist Medical Center, Inc · Lakeside Women'S Hospital, A Member of Integris He. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Whitney C Driver’s office at (405) 936-1000 to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Integris Baptist Medical Center, IncOklahoma City, OKAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Integris Health, which runs 10 hospitalsPatients rate it 3 of 5 · 73% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Rate of emergency department (ED) visits for patients receiving outpatient chemotherapy: 7.7 (6 to 9.7) · 449 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.319, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.375, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.328, Oct 2024 – Sep 2025
- Lakeside Women'S Hospital, A Member of Integris HeOklahoma City, OKAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Integris Health, which runs 10 hospitalsPatients rate it 4 of 5 · 79% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for Integris Baptist Medical Center, Inc
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 4 better, 3 the same, 1 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.7 (6 to 9.7) · 449 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.319 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.375 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.328 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.7 (0 to 1.48) · 3,084 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.63 to 1.05) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 188.97 (151.93 to 226.01) · 272 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 122 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.1 · 233 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.4 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.2 · 561 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.9 · 706 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.1 · 622 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.3 · 5,678 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0.02 to 0.37) · 11,917 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.09 to 0.44) · 12,739 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.49 (0.93 to 4.05) · 3,915 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.27 (1.05 to 3.48) · 1,571 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.79 (0.68 to 2.9) · 3,581 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.28 (7.42 to 15.13) · 1,595 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.98 (1.38 to 6.57) · 1,573 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.55 (0.24 to 2.87) · 954 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.68) · 9,877 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 39 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 1.364 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.345 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.957 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 280 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21 · 871 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 11.7 · 269 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.4 · 700 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.2 · 780 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 976 cases | None | Jul 2023 – Jun 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.1 (7.2 to 11.3) · 449 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 7 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 79 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 399 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 15.3 (12.2 to 19.2) · 1,911 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.2) · 1,688 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,285 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 57% |
| "YES", patients would definitely recommend the hospital | 73% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Lakeside Women'S Hospital, A Member of Integris He
Behind the star rating — Safety: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Abdominal HysterectomyInfections | 0.897 | No different | Oct 2024 – Sep 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9 to 16.7) · 306 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 169 cases | No different | Jan 2024 – Dec 2024 |
What patients said (271 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 91% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 82% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 80% |
| Staff "always" explained new medications | 80% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$7,460
Medicare paid this office $7,460 for 30 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 20 | $713 | $36 |
Who their Medicare patients are
30 Original Medicare patients in 2024. Average age 68 · Women 100% · Also on Medicaid 0% · Health risk score 0.82. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 60%.
The office billed $14,413, Medicare allowed $9,630 and paid $7,460; for 338 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 30 | 338 | 68 | 0.82 | $14,413 | $7,460 |
| 2023 | 22 | 508 | 68 | 0.55 | $16,101 | $9,673 |
| 2022 | 16 | 380 | 70 | 0.83 | $11,248 | $6,509 |
| 2021 | 16 | 262 | 72 | 0.55 | $10,946 | $5,704 |
| 2020 | 17 | 79 | 66 | 0.91 | $9,290 | $1,789 |
| 2019 | 17 | 19 | 68 | 0.71 | $4,845 | $1,305 |
| 2018 | 22 | 87 | 68 | 0.74 | $3,996 | $1,892 |
| 2017 | 19 | 272 | 67 | 0.73 | $10,306 | $4,996 |
| 2016 | 28 | 224 | 65 | 0.77 | $10,226 | $4,640 |
| 2015 | 22 | 101 | 69 | 0.68 | $5,040 | $2,530 |
| 2014 | 41 | 75 | 64 | 0.80 | $15,056 | $5,688 |
| 2013 | 28 | 59 | 63 | 0.54 | $10,600 | $3,317 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 14 | $515 | $37 |
2022: 1 service
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 12 | $436 | $36 |
2021: 1 service
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 12 | $443 | $37 |
2020: 1 service
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 12 | $454 | $38 |
2019: 1 service
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 13 | $438 | $34 |
2018: 1 service
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 18 | $644 | $36 |
2017: 1 service
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 14 | $500 | $36 |
2016: 2 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 14 | $490 | $35 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 12 | $255 | $21 |
2015: 2 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 12 | $420 | $35 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 13 | $276 | $21 |
2014: 1 service
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 18 | $383 | $21 |
2013: 2 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 14 | $479 | $34 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 11 | $237 | $22 |
Drugs they prescribed that Part D paid
$6,927
Pharmacies billed $6,927 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 45) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
36 generic and fewer than 11 brand-name prescriptions · $6,927 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 11 | $565 | $51 |
Year by year
| 2024 | 45 | 15 | 0% (0) | None | $6,927 |
| 2023 | 38 | 12 | 0% (0) | 29% | $5,430 |
| 2022 | 37 | 13 | None | 32% | $7,078 |
| 2021 | 46 | 11 | None | 41% | $2,858 |
| 2020 | 21 | None | None | None | $2,088 |
| 2019 | 32 | 11 | None | None | $3,477 |
| 2018 | 33 | None | 0% (0) | 0% | $1,660 |
| 2017 | 14 | None | 0% (0) | None | $1,148 |
| 2016 | 24 | None | 0% (0) | None | $1,052 |
| 2015 | 30 | None | None | None | $1,280 |
| 2014 | 70 | 20 | None | None | $2,152 |
| 2013 | 41 | 17 | None | None | $1,446 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2019: 1 drug
| Ibandronate | 11 | $692 | $63 |
2016: 1 drug
| Estradiol | 14 | $446 | $32 |
2014: 2 drugs
| Estradiol | 14 | $354 | $25 |
| Fluconazole | 12 | $152 | $13 |
Money from drug and device companies
$135 in 2025
| 2025 | 2 | 11 | None | $135 |
| 2024 | 7 | 13 | None | $223 |
| 2023 | 4 | 11 | None | $181 |
| 2022 | 4 | 26 | None | $378 |
| 2021 | 6 | 19 | None | $278 |
| 2020 | 4 | 5 | None | $74 |
| 2019 | 5 | 10 | None | $175 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Organon | Nexplanon | $104 | 9 payments
|
| Hologic Sales and Service | Thinprep 2000 Processor | $30 | 2 payments
|
See all 11 published payments
| Organon | Meals · 2025-11-24 | Nexplanon | $8 |
| Organon | Meals · 2025-10-09 | Nexplanon | $12 |
| Organon | Meals · 2025-09-03 | Nexplanon | $18 |
| Organon | Meals · 2025-07-28 | Nexplanon | $13 |
| Organon | Meals · 2025-06-23 | Nexplanon | $16 |
| Organon | Meals · 2025-05-28 | Nexplanon | $13 |
| Organon | Meals · 2025-04-10 | Nexplanon | $10 |
| Hologic Sales and Service | Meals · 2025-03-06 | Thinprep 2000 Processor | $16 |
| Organon | Meals · 2025-02-24 | Nexplanon | $13 |
| Organon | Meals · 2025-01-29 | None | $2 |
| Hologic Sales and Service | Meals · 2025-01-10 | Aptima | $14 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $223
| Hologic Sales and Service | Aptima | $60 | 3 payments
|
| Organon | Nexplanon | $58 | 5 payments
|
| Mayne Pharma Commercial | None | $27 | 1 payment
|
| Radius Health | Tymlos | $23 | 1 payment
|
| Sumitomo Pharma America | Myfembree | $22 | 1 payment
|
| Shield Therapeutics | Accrufer | $16 | 1 payment
|
| Amgen | Evenity | $16 | 1 payment
|
2023: $181
| Organon | Nexplanon | $82 | 6 payments
|
| AbbVie | Qulipta | $60 | 3 payments
|
| Amgen | Evenity | $24 | 1 payment
|
| Astellas Pharma US | Veozah | $15 | 1 payment
|
2022: $378
| Abbvie | Qulipta | $243 | 18 payments
|
| Organon | Nexplanon | $101 | 6 payments
|
| Mylan Pharmaceuticals | Xulane | $20 | 1 payment
|
| Pfizer | Premarin | $14 | 1 payment
|
2021: $278
| AbbVie | Lo Loestrin Fe | $147 | 9 payments
|
| Organon | Nexplanon | $57 | 4 payments
|
| Avion Pharmaceuticals | Balcoltra | $35 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Kyleena | $14 | 1 payment
|
| TherapeuticsMD | Annovera | $13 | 1 payment
|
| Merck Sharp & Dohme | Nexplanon | $11 | 1 payment
|
2020: $74
| Merck Sharp & Dohme | Nexplanon | $24 | 2 payments
|
| Hologic | Thinprep | $22 | 1 payment
|
| Avion Pharmaceuticals | Balcoltra | $15 | 1 payment
|
| CooperSurgical | Uterine Manipulators & Injectors | $13 | 1 payment
|
2019: $175
| AbbVie | Orilissa | $85 | 4 payments
|
| Avion Pharmaceuticals | Balcoltra | $43 | 3 payments
|
| Roche Diagnostics | MD Cobas Instruments and Reagents | $18 | 1 payment
|
| Duchesnay USA | Bonjesta | $16 | 1 payment
|
| Acessa Health | Acessa | $13 | 1 payment
|
Checkups this office reported
6 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 81.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 1%That's few of the people this applied to. | 1,360 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 87%That's most of the people this applied to. | 23 |
| Breast cancer screeningEligible women who got a mammogram | 80%That's most of the people this applied to. | 152 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 96%That's most of the people this applied to. | 1,189 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 46% | 2,897 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 40%That's less than half. | 1,018 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- Uses standard treatment protocols
Professional record
- NPI
- 1770743825
- Licence
- OK 26301
- Trained
- University of Oklahoma College of Medicine, 2008 · 18 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 5300 N Independence Ave, Suite 280, Oklahoma City, OK, 73112
- NPI first listed
- 2008-06-12
- NPI last updated
- 2015-05-08
This is when the NPI record was last certified, not a medical board exam.